Charles River Labs Intl buy The Goldman Sachs Group, Inc.
Start price
06.06.24
/
50%
€199.65
Target price
06.06.25
€266.42
Performance (%)
-36.41%
End price
07.06.25
€126.95
Summary
This prediction ended on 07.06.25 with a price of €126.95. Massive losses of -36.41% were the result for the BUY prediction by The_Goldman_Sachs_Gr. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 1.549% | 1.549% | 25.378% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $290.00 price target on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€159.40
23.01.25
23.01.25
€182.70
23.01.26
23.01.26
15.50%
24.01.26
24.01.26
